Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Hanze Voorpagina
English
Nederlands
Voorpagina
Profielen
Onderzoekseenheden
Projecten
Onderzoeksoutput
Datasets
Activiteiten
Knipsels
Prijzen
Zoeken op expertise, naam of affiliatie
Evaluation of screening for speech/language and non-speech language
Liesbeth Dieleman
Talig Functioneren en Gezond ouder worden
Onderzoeksoutput
:
Website
›
Other research output
Overzicht
Vingerafdruk
Vingerafdruk
Duik in de onderzoeksthema's van 'Evaluation of screening for speech/language and non-speech language'. Samen vormen ze een unieke vingerafdruk.
Sorteer per
Gewicht
Alfabetische volgorde
Keyphrases
Language Delay
100%
Non-speech
100%
Speech-language
100%
Practice-based
33%
Child Health Care
33%
Language Outcomes
33%
Speech Outcomes
33%
Netherlands
16%
Quality of Life
16%
Psychological Well-being
16%
Language Development
16%
Older children
16%
Comorbidity
16%
Developmental Disorders
16%
Early childhood
16%
Children at Risk
16%
Speech Development
16%
Position Statement
16%
Appropriate Care
16%
Succes
16%
Taal
16%
Health Benefit Costs
16%
Health Care Screening
16%
Young Age
16%
Two-year-olds
16%
Language Problems
16%
Dyslexia
16%
Psychology
Healthcare
100%
Comorbidity
50%
Quality of Life
50%
Language Development
50%
Developmental Disorder
50%
Dyslexia
50%
Attention Deficit Hyperactivity Disorder
50%
Wellbeing
50%
Psychology
50%
Medicine and Dentistry
Speech and Language
100%
Speech Production
100%
Speech Delay
37%
Language Delay
37%
Health Care
25%
Child Health
25%
Psychological Well-Being
12%
Quality of Life
12%
Speech Development
12%
Language Development
12%
Attention Deficit Disorder
12%
Cost Benefit Analysis
12%
Developmental Disorder
12%
Dyslexia
12%
Comorbidity
12%
Nursing and Health Professions
Logopedics
100%
Speech Delay
50%
Practice Guideline
33%
Child Health Care
33%
Quality of Life
16%
Cost Benefit Analysis
16%
Developmental Disorder
16%
Attention Deficit Disorder
16%
Dyslexia
16%
Comorbidity
16%
Neuroscience
Language Delay
100%
Comorbidity
33%